Selbyville, Delaware, July 15, 2020 (GLOBE NEWSWIRE) -- According to Market Study Report LLC Global infectious disease test device market attained a valuation of USD 16.4 billion in 2019 and projected to USD 26.8 billion by 2027, with a CAGR of 5.6% over 2020-2027. Increased pervasiveness of infectious diseases such as HPV, influenza, hepatitis, tuberculosis, and HIV is fueling the industry growth, cites the report. Moreover, extensive use of genomics & proteomics and molecular diagnostics technologies for infectious disease testing owing to rising patient awareness towards benefits of personalized medicines serves as a major impetus for the market growth.
In April 2015, Genome Canada, a funding source for genomics and proteomics, declared its plan for USD 16 million investment between April 2015 to March 2017. Besides this, NCBI stated that globally 17 million HIV-positive individuals are receiving life-extending drugs as compared to only 2.2 million people who were on antiretroviral therapy (ART) in 2005. Thus, inflow of investments towards development of new treatments and growing availability of testing kits across the globe is rendering a positive impact on global infectious disease test device market.
For the uninitiated, infectious disease diagnostics involves detecting presence of foreign antigen/organism by using specialized diagnostic kits. Majority of the standardized test kits available are designed for testing bacterial infections and sexually transmitted diseases. However, malaria, leptospirosis, dengue, and other diagnostic test are soon to be replaced by molecular techniques in the coming future.
Request Sample copy of this Report @ https://www.marketstudyreport.com/request-a-sample/2706213/
Despite the positive outlook of the industry, unfavorable reimbursement scenario will hinder the market expansion. For instance, Medicare has reworked its reimbursement mechanism for some in-vitro diagnostic (IVD) tests, including molecular infectious disease tests. Some of these molecular pathology tests are charged using unlisted codes as they do not have their own HCPS (Healthcare Common Procedure Coding System), which negatively impacts the industry growth. Additionally, reimbursement for IVD tests is defined by the U.S. reimbursement system which only covers commercialized tests and ignores those primarily used for R&D applications, acting as major challenge for the industry.
Regional analysis of the market:
On the geographical front, North America held 44% share of global infectious disease test device market in 2019 and is expected to follow similar growth trend over the forecast duration. High awareness among healthcare professionals as well as patients, proactive government initiatives, and well-established healthcare infrastructure are supporting the regional industry expansion.
Meanwhile, Asia Pacific market is anticipated to expand at a rapid pace through 2027, set by favorable government initiatives for infectious disease testing, rising burden of unmet medical needs, improving economy and subsequent rise in disposable income. Furthermore, increased healthcare expenditure in emerging economies like India, China, and South Korea is boosting the industry growth in APAC.
To access a sample copy or view this report in detail along with the table of contents, please click the link below:
https://www.marketstudyreport.com/reports/global-infectious-disease-test-device-market-size-research
Global Infectious Disease Test Device Market Product & Service Analysis (Revenue, USD billion, 2017-2027)
- Assays, Kits, & Reagents
- Services and Software
- Instruments
Global Infectious Disease Test Device Market Disease Type Analysis (Revenue, USD billion, 2017-2027)
- Hepatitis
- CT/NG
- HIV
- HAIs
- Influenza
- HPV
- TB
- Other Diseases
Global Infectious Disease Test Device Market Technology Analysis (Revenue, USD billion, 2017-2027)
- Immunodiagnostics
- PCR
- Clinical Microbiology
- INAAT
- DNA Microarrays
- DNA Sequencing & NGS
- Other Technologies
Global Infectious Disease Test Device Market End User Analysis (Revenue, USD billion, 2017-2027)
- Hospitals/Clinical Laboratories
- Physician Offices
- Reference Laboratories
- Academic/Research Institutes
- Other End-users
Global Infectious Disease Test Device Market Regional Analysis (Revenue, USD billion, 2017-2027)
North America
- Canada
- U.S.
Europe
- U.K.
- France
- Spain
- Italy
- Germany
- Rest of Europe
Asia Pacific
- China
- India
- South Korea
- Japan
- Australia
- Rest of Asia Pacific
Latin America
- Brazil
- Mexico
Rest of the World
Global Infectious Disease Test Device Market Competitive Landscape Analysis (Revenue, USD billion, 2017-2027)
- Thermo Fisher Scientific
- Siemens AG
- Roche Diagnostics
- Quidel
- Meridian Bioscience
- Luminex
- DiaSorin
- Danaher Corporation
- Bio-Rad Laboratories
- BioMérieux SA
- Becton, Dickinson and Company
- Abbott Laboratories
Table of Content:
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Infectious disease test device Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Infectious disease test device Market Dynamics
3.1. Infectious disease test device Market Impact Analysis (2018-2027)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Infectious disease test device Market: Industry Analysis
4.1. Portera??s 5 Force Model
4.2. PEST Analysis
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Infectious disease test device Market, by Product and Service
5.1. Market Snapshot
5.2. Global Infectious disease test device Market by Product and Service, Performance - Potential Analysis
5.3. Global Infectious disease test device Market Estimates & Forecasts by Product and Service 2017-2027 (USD Billion)
5.4. Infectious disease test device Market, Sub Segment Analysis
Chapter 6. Global Infectious disease test device Market, by Disease Type
6.1. Market Snapshot
6.2. Global Infectious disease test device Market by Disease Type, Performance - Potential Analysis
6.3. Global Infectious disease test device Market Estimates & Forecasts by Disease Type2017-2027 (USD Billion)
6.4. Infectious disease test device Market, Sub Segment Analysis
6.4.1. Hepatitis
6.4.2. HIV
6.4.3. CT/NG
6.4.4. HAIs
6.4.5. HPV
6.4.6. TB
6.4.7. Influenza
Chapter 7. Global Infectious disease test device Market, by Technology
7.1. Market Snapshot
7.2. Global Infectious disease test device Market by Technology, Performance - Potential Analysis
7.3. Global Infectious disease test device Market Estimates & Forecasts by Technology 2017-2027 (USD Billion)
7.4. Infectious disease test device Market, Sub Segment Analysis
7.4.1. Immunodiagnostics
7.4.2. Clinical Microbiology
7.4.3. PCR
7.4.4. INAAT
7.4.5. DNA Sequencing & NGS
7.4.6. DNA Microarrays
Chapter 8. Global Infectious disease test device Market, by End User
8.1. Market Snapshot
8.2. Global Infectious disease test device Market by End User, Performance - Potential Analysis
8.3. Global Infectious disease test device Market Estimates & Forecasts by End User 2017-2027 (USD Billion)
8.4. Infectious disease test device Market, Sub Segment Analysis
8.4.1. Hospitals/Clinical Laboratories
8.4.2. Reference Laboratories
8.4.3. Physician Offices
8.4.4. Academic/Research Institutes
Chapter 9. Global Infectious disease test device Market, Regional Analysis
Related Report:
Respiratory Disease Testing Market Size, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2020 – 2026
Respiratory Disease Testing Market size exhibit close to 8.5% CAGR throughout the forecast timespan, as per new research report. Respiratory disease testing is widely used to measure lung disorders by measuring the capacity to hold, move air and to absorb oxygen. The industry growth is attributed to the rise in respiratory diseases such as chronic obstructive pulmonary disease (COPD), asthma, tuberculosis, and COVID-19 among others.
Respiratory illnesses are a common problem for a majority of people across the globe. Often, individuals are genetically more inclined to develop respiratory conditions. However, it has been proven that the workplace conditions and environmental exposures can also play a vital role in people developing respiratory issues. Apart from these factors, smoking is classified as the most common determinant that causes respiratory diseases.
About US:
Market Study Report, LLC. is a hub for market intelligence products and services.
We streamline the purchase of your market research reports and services through a single integrated platform by bringing all the major publishers and their services at one place.
Our customers partner with Market Study Report, LLC. to ease their search and evaluation of market intelligence products and services and in turn focus on their company's core activities.
If you are looking for research reports on global or regional markets, competitive information, emerging markets and trends or just looking to stay on top of the curve then Market Study Report, LLC. is the platform that can help you in achieving any of these objectives.